Product Name | AM 580 |
Description |
Rar agonist |
Purity | >98% (HPLC); NMR (conforms) |
CAS No. | 102121-60-8 |
Molecular Formula | C22H25NO3 |
Molecular Weight | 351.4 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Agonist |
Solubility | May be dissolved in DMSO (35 mg/ml); or Ethanol (18 mg/ml) |
Source | Synthetic |
Appearance | Off-white powder |
SMILES | CC1(CCC(C2=C1C=CC(=C2)C(=O)NC3=CC=C(C=C3)C(=O)O)(C)C)C |
InChI | InChI=1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-15(7-10-17(18)21)19(24)23-16-8-5-14(6-9-16)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26) |
InChIKey | SZWKGOZKRMMLAJ-UHFFFAOYSA-N |
Safety Phrases |
Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection |
Cite This Product | AM 580 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-600) |
Alternative Names | 4-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic acid; CD336; NSC 608001; Ro 40-6055 |
Research Areas | Cancer, Cell Signaling, Epigenetics and Nuclear Signaling, Neuroscience, Oxidative Stress, Transcription |
PubChem ID | 2126 |
Scientific Background | AM-580, a benzoic derivative of retinoic acid and a selective RAR-α agonist, has been shown to significantly reduce the production of Th1 cytokines but promote Th2 cytokines in human PBMCs7 and to inhibit microglial activation, thus acting beneficially in Alzheimer's disease treatment. It also is known to inhibit tumor cell proliferation and induces apoptosis. |
References | 1. Wang O., Thome R., Rostami A., Ma C-G., Zhang G-X. (2019) Nature. 16: 727-729. 2. Bosch A., et al. (2012) Breast Cancer Res. 14(4): R121. |
Reviews
There are no reviews yet.